Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Net Income

CAPRICOR THERAPEUTICS, INC. Net Income

CAPRICOR THERAPEUTICS, INC. (CAPR) reported Net Income of -$40.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-08-14

  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$40.73M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$33.94M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$30.17M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$24.57M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2022 was -$29.02M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2021 was -$20.02M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2020 was -$13.66M.
  • CAPRICOR THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2019 was -$7.64M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 5 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filedNet Income (Loss) Attributable to Parent 71 monthNet Income (Loss) Attributable to Parent 74 monthNet Income (Loss) Attributable to Parent 77 monthNet Income (Loss) Attributable to Parent 80 monthNet Income (Loss) Attributable to Parent 83 monthNet Income (Loss) Attributable to Parent 86 monthNet Income (Loss) Attributable to Parent 89 monthNet Income (Loss) Attributable to Parent 92 monthNet Income (Loss) Attributable to Parent 95 monthNet Income (Loss) Attributable to Parent 98 monthNet Income (Loss) Attributable to Parent 102 monthNet Income (Loss) Attributable to Parent 105 month
2026-06-30-$40.73M
10-Q · filed 2026-08-14
-$74.67M
10-Q · filed 2026-08-14
-$104.85M
derived: sum of 3 quarters · filed 2026-08-14
-$129.42M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$33.94M
10-Q · filed 2026-08-14
-$64.11M
derived: sum of 2 quarters · filed 2026-08-14
-$88.68M
derived: sum of 3 quarters · filed 2026-08-14
-$114.59M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$30.17M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-10
-$54.74M
derived: sum of 2 quarters · filed 2026-04-10
-$80.65M
derived: sum of 3 quarters · filed 2026-08-14
-$105.04M
DEF 14A · filed 2026-04-10
2025-09-30-$24.57M
10-Q · filed 2025-11-10
-$50.48M
derived: sum of 2 quarters · filed 2026-08-14
-$74.87M
10-Q · filed 2025-11-10
-$81.99M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$25.91M
10-Q · filed 2026-08-14
-$50.30M
10-Q · filed 2026-08-14
-$57.42M
derived: sum of 3 quarters · filed 2026-08-14
-$69.98M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$24.39M
10-Q · filed 2026-08-14
-$31.51M
derived: sum of 2 quarters · filed 2026-08-14
-$44.06M
derived: sum of 3 quarters · filed 2026-08-14
-$55.06M
derived: sum of 4 quarters · filed 2026-08-14
2024-12-31-$7.12M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-10
-$19.67M
derived: sum of 2 quarters · filed 2026-04-10
-$30.67M
derived: sum of 3 quarters · filed 2026-04-10
-$40.47M
DEF 14A · filed 2026-04-10
2024-09-30-$12.56M
10-Q · filed 2025-11-10
-$23.56M
derived: sum of 2 quarters · filed 2025-11-10
-$33.35M
10-Q · filed 2025-11-10
-$34.11M
derived: sum of 4 quarters · filed 2026-04-10
2024-06-30-$11.00M
10-Q · filed 2025-11-10
-$20.79M
10-Q · filed 2025-08-11
-$21.56M
derived: sum of 3 quarters · filed 2026-04-10
-$27.95M
derived: sum of 4 quarters · filed 2026-04-10
2024-03-31-$9.79M
10-Q · filed 2025-11-10
-$10.56M
derived: sum of 2 quarters · filed 2026-04-10
-$16.95M
derived: sum of 3 quarters · filed 2026-04-10
-$24.31M
derived: sum of 4 quarters · filed 2026-04-10
2023-12-31-$762.09K
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-10
-$7.15M
derived: sum of 2 quarters · filed 2026-04-10
-$14.52M
derived: sum of 3 quarters · filed 2026-04-10
-$22.29M
DEF 14A · filed 2026-04-10
2023-09-30-$6.39M
10-Q · filed 2024-11-14
-$13.76M
derived: sum of 2 quarters · filed 2024-11-14
-$21.53M
10-Q · filed 2024-11-14
-$29.25M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$7.37M
10-Q · filed 2024-11-14
-$15.13M
10-Q · filed 2024-08-08
-$22.86M
derived: sum of 3 quarters · filed 2024-11-14
-$29.23M
derived: sum of 4 quarters · filed 2024-11-14
2023-03-31-$7.77M
10-Q · filed 2024-11-14
-$15.49M
derived: sum of 2 quarters · filed 2024-11-14
-$21.86M
derived: sum of 3 quarters · filed 2024-11-14
-$28.97M
derived: sum of 4 quarters · filed 2024-11-14
2022-12-31-$7.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11
-$14.09M
derived: sum of 2 quarters · filed 2024-03-11
-$21.20M
derived: sum of 3 quarters · filed 2024-03-11
-$29.02M
10-K · filed 2024-03-11
2022-09-30-$6.37M
10-Q · filed 2023-11-14
-$13.48M
derived: sum of 2 quarters · filed 2023-11-14
-$21.30M
10-Q · filed 2023-11-14
-$27.49M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$7.11M
10-Q · filed 2023-11-14
-$14.93M
10-Q · filed 2023-08-08
-$21.12M
derived: sum of 3 quarters · filed 2023-11-14
-$25.05M
derived: sum of 4 quarters · filed 2023-11-14
2022-03-31-$7.82M
10-Q · filed 2023-11-14
-$14.01M
derived: sum of 2 quarters · filed 2023-11-14
-$17.94M
derived: sum of 3 quarters · filed 2023-11-14
-$22.69M
derived: sum of 4 quarters · filed 2023-11-14
2021-12-31-$6.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17
-$10.12M
derived: sum of 2 quarters · filed 2023-03-17
-$14.87M
derived: sum of 3 quarters · filed 2023-03-17
-$20.02M
10-K · filed 2023-03-17
2021-09-30-$3.93M
10-Q · filed 2022-11-10
-$8.68M
derived: sum of 2 quarters · filed 2022-11-10
-$13.83M
10-Q · filed 2022-11-10
-$18.01M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$4.75M
10-Q · filed 2022-11-10
-$9.90M
10-Q · filed 2022-08-12
-$14.08M
derived: sum of 3 quarters · filed 2022-11-10
-$17.99M
derived: sum of 4 quarters · filed 2022-11-10
2021-03-31-$5.15M
10-Q · filed 2022-11-10
-$9.33M
derived: sum of 2 quarters · filed 2022-11-10
-$13.24M
derived: sum of 3 quarters · filed 2022-11-10
-$16.72M
derived: sum of 4 quarters · filed 2022-11-10
2020-12-31-$4.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$8.09M
derived: sum of 2 quarters · filed 2022-03-11
-$11.57M
derived: sum of 3 quarters · filed 2022-03-11
-$13.66M
10-K · filed 2022-03-11
2020-09-30-$3.91M
10-Q · filed 2021-11-12
-$7.39M
derived: sum of 2 quarters · filed 2021-11-12
-$9.48M
10-Q · filed 2021-11-12
-$10.95M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$3.48M
10-Q · filed 2021-11-12
-$5.57M
10-Q · filed 2021-08-13
-$7.04M
derived: sum of 3 quarters · filed 2021-11-12
-$8.64M
derived: sum of 4 quarters · filed 2021-11-12
2020-03-31-$2.08M
10-Q · filed 2021-11-12
-$3.55M
derived: sum of 2 quarters · filed 2021-11-12
-$5.16M
derived: sum of 3 quarters · filed 2021-11-12
-$7.21M
derived: sum of 4 quarters · filed 2021-11-12
2019-12-31-$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$3.08M
derived: sum of 2 quarters · filed 2021-03-15
-$5.12M
derived: sum of 3 quarters · filed 2021-03-15
-$7.64M
10-K · filed 2021-03-15
2019-09-30-$1.61M
10-Q · filed 2020-11-13
-$3.65M
derived: sum of 2 quarters · filed 2020-11-13
-$6.17M
10-Q · filed 2020-11-13
-$9.43M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$2.05M
10-Q · filed 2020-11-13
-$4.57M
10-Q · filed 2020-08-10
-$7.83M
derived: sum of 3 quarters · filed 2020-11-13
-$11.96M
derived: sum of 4 quarters · filed 2020-11-13
2019-03-31-$2.52M
10-Q · filed 2020-11-13
-$5.78M
derived: sum of 2 quarters · filed 2020-11-13
-$9.92M
derived: sum of 3 quarters · filed 2020-11-13
-$14.04M
derived: sum of 4 quarters · filed 2020-11-13
2018-12-31-$3.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
-$7.40M
derived: sum of 2 quarters · filed 2020-03-27
-$11.52M
derived: sum of 3 quarters · filed 2020-03-27
-$15.19M
10-K · filed 2020-03-27
2018-09-30-$4.14M
10-Q · filed 2019-11-08
-$4.14M
10-Q · filed 2018-11-14
-$8.26M
derived: sum of 2 quarters · filed 2019-11-08
-$11.93M
10-Q · filed 2019-11-08
$373.95K
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$4.12M
10-Q · filed 2019-11-08
-$7.80M
10-Q · filed 2019-08-08
$4.51M
derived: sum of 3 quarters · filed 2019-11-08
$1.78M
derived: sum of 4 quarters · filed 2019-11-08
2018-03-31-$3.67M
10-Q · filed 2019-11-08
$8.63M
derived: sum of 2 quarters · filed 2019-11-08
$5.90M
derived: sum of 3 quarters · filed 2019-11-08
$2.43M
derived: sum of 4 quarters · filed 2019-11-08
2017-12-31$12.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$9.57M
derived: sum of 2 quarters · filed 2019-03-29
$6.10M
derived: sum of 3 quarters · filed 2019-03-29
$2.43M
10-K · filed 2019-03-29
2017-09-30-$2.73M
10-Q · filed 2018-11-14
-$6.21M
derived: sum of 2 quarters · filed 2018-11-14
-$9.87M
10-Q · filed 2018-11-14
-$14.39M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$3.47M
10-Q · filed 2018-08-13
-$7.14M
10-Q · filed 2018-08-13
-$11.66M
derived: sum of 3 quarters · filed 2018-08-13
-$16.99M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$3.67M
10-Q · filed 2018-05-14
-$8.18M
derived: sum of 2 quarters · filed 2018-05-14
-$13.52M
derived: sum of 3 quarters · filed 2018-05-14
-$18.21M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$9.85M
derived: sum of 2 quarters · filed 2018-03-22
-$14.54M
derived: sum of 3 quarters · filed 2018-03-22
-$18.81M
10-K · filed 2018-03-22
2016-09-30-$5.33M
10-Q · filed 2017-11-14
-$10.02M
derived: sum of 2 quarters · filed 2017-11-14
-$14.29M
10-Q · filed 2017-11-14
-$17.63M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30-$4.69M
10-Q · filed 2017-08-14
-$8.96M
10-Q · filed 2017-08-14
-$12.30M
derived: sum of 3 quarters · filed 2017-08-14
-$15.21M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$4.27M
10-Q · filed 2017-05-15
-$7.61M
derived: sum of 2 quarters · filed 2017-05-15
-$10.52M
derived: sum of 3 quarters · filed 2017-05-15
-$13.65M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$3.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$6.26M
derived: sum of 2 quarters · filed 2017-03-16
-$9.38M
derived: sum of 3 quarters · filed 2017-03-16
-$12.86M
10-K · filed 2017-03-16
2015-09-30-$2.91M
10-Q · filed 2016-11-14
-$6.04M
derived: sum of 2 quarters · filed 2016-08-15
-$9.51M
10-Q · filed 2016-11-14
-$11.44M
derived: sum of 4 quarters · filed 2016-08-15
2015-06-30-$3.12M
10-Q · filed 2016-08-15
-$6.60M
10-Q · filed 2016-08-15
-$8.53M
derived: sum of 3 quarters · filed 2016-08-15
-$10.07M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$3.48M
10-Q · filed 2016-05-13
-$5.40M
derived: sum of 2 quarters · filed 2016-05-13
-$6.95M
derived: sum of 3 quarters · filed 2016-05-13
-$8.48M
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31-$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$3.47M
derived: sum of 2 quarters · filed 2016-03-30
-$5.01M
derived: sum of 3 quarters · filed 2016-03-30
-$6.22M
10-K · filed 2016-03-30
2014-09-30-$1.54M
10-Q · filed 2015-11-13
-$3.08M
derived: sum of 2 quarters · filed 2015-11-13
-$4.29M
10-Q · filed 2015-11-13
-$8.59M
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30-$1.53M
10-Q · filed 2015-08-14
-$2.74M
10-Q · filed 2015-08-14
-$7.05M
derived: sum of 3 quarters · filed 2015-08-14
-$8.59M
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31-$1.21M
10-Q · filed 2015-05-13
-$5.52M
derived: sum of 2 quarters · filed 2015-05-13
-$7.06M
derived: sum of 3 quarters · filed 2015-05-13
-$8.69M
derived: sum of 4 quarters · filed 2015-05-13
-$17.31M
10-Q · filed 2014-05-15
2013-12-31-$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
-$5.85M
derived: sum of 2 quarters · filed 2015-03-16
-$7.47M
derived: sum of 3 quarters · filed 2015-03-16
-$8.89M
10-K · filed 2015-03-16
-$16.10M
10-K · filed 2014-03-31
2013-09-30-$1.55M
10-Q · filed 2014-11-14
-$348.45K
10-Q · filed 2013-11-14
-$3.17M
derived: sum of 2 quarters · filed 2014-11-14
-$4.59M
10-Q · filed 2014-11-14
-$1.43M
10-Q · filed 2013-11-14
-$4.97M
derived: sum of 4 quarters · filed 2014-11-14
-$48.14M
10-Q · filed 2013-11-14
2013-06-30-$1.62M
10-Q · filed 2014-08-14
-$597.62K
10-Q · filed 2013-08-14
-$3.04M
10-Q · filed 2014-08-14
-$1.08M
10-Q · filed 2013-08-14
-$3.42M
derived: sum of 3 quarters · filed 2014-08-14
-$3.99M
derived: sum of 4 quarters · filed 2014-08-14
-$47.79M
10-Q · filed 2013-08-14
2013-03-31-$1.42M
10-Q · filed 2014-05-15
-$482.76K
10-Q · filed 2013-06-21
-$1.80M
derived: sum of 2 quarters · filed 2014-05-15
-$2.36M
derived: sum of 3 quarters · filed 2014-05-15
-$2.72M
derived: sum of 4 quarters · filed 2014-05-15
-$47.19M
10-Q · filed 2013-06-21
2012-12-31-$380.21K
derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-15
-$946.44K
derived: sum of 2 quarters · filed 2014-05-15
-$1.30M
derived: sum of 3 quarters · filed 2014-05-15
-$2.07M
10-Q · filed 2014-05-15
-$1.89M
10-K · filed 2013-06-21
-$46.71M
10-K · filed 2013-06-21
2012-09-30-$566.23K
10-Q · filed 2013-11-14
-$919.17K
derived: sum of 2 quarters · filed 2013-11-14
-$1.69M
10-Q · filed 2013-11-14
$380.03K
derived: sum of 4 quarters · filed 2014-05-15
-$46.51M
10-Q · filed 2013-06-21
2012-06-30-$352.93K
10-Q/A · filed 2012-09-10
-$1.12M
10-Q · filed 2013-08-14
$946.26K
derived: sum of 3 quarters · filed 2014-05-15
-$197.81K
derived: sum of 4 quarters · filed 2014-05-15
-$45.94M
10-Q/A · filed 2012-09-10
2012-03-31-$771.88K
10-Q · filed 2013-06-21
$1.30M
derived: sum of 2 quarters · filed 2014-05-15
$155.12K
derived: sum of 3 quarters · filed 2014-05-15
-$725.41K
derived: sum of 4 quarters · filed 2014-05-15
-$45.59M
10-Q · filed 2012-05-15
2011-12-31$2.07M
derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-15
$927.00K
derived: sum of 2 quarters · filed 2014-05-15
$46.47K
derived: sum of 3 quarters · filed 2014-05-15
-$1.15M
10-Q · filed 2014-05-15
-$4.88M
10-K · filed 2012-04-02
-$44.81M
10-K · filed 2012-04-02
2011-09-30-$1.14M
10-Q · filed 2013-06-21
-$2.02M
derived: sum of 2 quarters · filed 2013-06-21
-$3.22M
10-Q · filed 2013-06-21
$959.69K
derived: sum of 4 quarters · filed 2014-05-15
-$43.15M
10-Q · filed 2011-11-14
2011-06-30-$880.53K
10-Q/A · filed 2012-09-10
-$2.08M
10-Q/A · filed 2012-09-10
$2.10M
derived: sum of 3 quarters · filed 2014-05-15
$294.27K
derived: sum of 4 quarters · filed 2014-05-15
-$42.01M
10-Q · filed 2011-08-15
2011-03-31-$1.20M
10-Q · filed 2012-05-15
$2.98M
derived: sum of 2 quarters · filed 2014-05-15
$1.17M
derived: sum of 3 quarters · filed 2014-05-15
-$319.72K
derived: sum of 4 quarters · filed 2014-05-15
2010-12-31$4.18M
derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-15
$2.37M
derived: sum of 2 quarters · filed 2014-05-15
$876.07K
derived: sum of 3 quarters · filed 2014-05-15
-$1.06M
10-Q · filed 2014-05-15
-$6.03M
10-Q · filed 2011-08-15
2010-09-30-$1.81M
10-Q · filed 2011-11-14
-$3.30M
derived: sum of 2 quarters · filed 2011-11-14
-$5.24M
10-Q · filed 2011-11-14
2010-06-30-$1.49M
10-Q · filed 2011-08-15
-$3.43M
10-Q · filed 2011-08-15
2009-12-31-$148.97K
10-Q · filed 2014-05-15
-$7.87M
10-Q · filed 2011-08-15
2008-12-31-$630.86K
10-Q · filed 2014-05-15
-$13.13M
10-Q · filed 2011-08-15
2007-12-31-$979.08K
10-Q · filed 2014-05-15
-$10.30M
10-Q · filed 2011-08-15
2006-12-31-$1.17M
10-Q · filed 2014-05-15
-$2.58M
10-Q · filed 2011-08-15
2005-12-31-$10.04K
10-Q · filed 2013-11-14
$36.00
10-Q · filed 2014-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63